Antiplatelet agents: a review.
作者信息
Gantmacher M L
出版信息
J R Soc Med. 1979 Jul;72(7):513-9. doi: 10.1177/014107687907200710.
Abstract
摘要
相似文献
1
Antiplatelet agents: a review.抗血小板药物：综述
J R Soc Med. 1979 Jul;72(7):513-9. doi: 10.1177/014107687907200710.
2
[Treatment with antiplatelet drugs. Current status of knowledge].
Recenti Prog Med. 1979 Sep;67(3):346-67.
3
Platelet suppressive therapy.
Br Med Bull. 1978 May;34(2):183-90. doi: 10.1093/oxfordjournals.bmb.a071490.
4
Use of common antiplatelet drugs for vascular diseases.
Geriatrics. 1983 Nov;38(11):75-95.
5
The current status of platelet suppressive drugs in the treatment of thrombosis.
Thromb Diath Haemorrh. 1975 Jun 30;33(3):406-16.
6
Antiplatelet therapy.
Clin Haematol. 1981 Jun;10(2):497-520.
7
Antiplatelet agents in coronary disease: are they of prophylactic value?冠心病中的抗血小板药物：它们具有预防价值吗？
Drugs. 1978 Jun;15(6):464-71. doi: 10.2165/00003495-197815060-00004.
8
Platelet function inhibitors: their clinical use.
Adv Intern Med. 1978;23:251-64.
9
[Correction of thrombophilia].
Minerva Cardioangiol. 1981 Jan-Feb;29(1-2):13-8.
10
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.血小板抑制药物在血栓性疾病中的批判性评估。
Prog Hematol. 1975;9:229-54.
引用本文的文献
1
Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets.降血脂药物在分离的大鼠肝细胞中被激活为酰基辅酶A酯。用人肝匀浆和人血小板检测药物激活情况。
Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):289-95. doi: 10.1042/bj2840289.
本文引用的文献
1
Use of Persantine in preventing thromboembolism following valve replacement.
Am Surg. 1972 Aug;38(8):432-5.
2
Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
N Engl J Med. 1971 Jun 24;284(25):1391-4. doi: 10.1056/NEJM197106242842501.
3
Controlled trial of dipyridamole in cerebral vascular disease.双嘧达莫治疗脑血管疾病的对照试验。
Br Med J. 1969 Mar 8;1(5644):614-5. doi: 10.1136/bmj.1.5644.614.
4
Dipyridamole: a controlled trial of its effect in acute myocardial infarction.双嘧达莫：其对急性心肌梗死疗效的对照试验。
Br Med J. 1968 Nov 9;4(5627):366-8. doi: 10.1136/bmj.4.5627.366.
5
Platelet survival in patients with rheumatic heart disease.
N Engl J Med. 1974 Mar 7;290(10):537-9. doi: 10.1056/NEJM197403072901003.
6
Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy.与抗血小板聚集治疗相关的颈动脉短暂性脑缺血发作发生率的差异。
Stroke. 1973 Sep-Oct;4(5):732-6. doi: 10.1161/01.str.4.5.732.
7
Platelet survival and adhesiveness in recurrent venous thrombosis.复发性静脉血栓形成中血小板的存活与黏附性
N Engl J Med. 1973 May 31;288(22):1148-52. doi: 10.1056/NEJM197305312882203.
8
9
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.一项关于乙酰水杨酸在心肌梗死死亡率二级预防中的随机对照试验。
Br Med J. 1974 Mar 9;1(5905):436-40. doi: 10.1136/bmj.1.5905.436.
10
Controlled trial of clofibrate in cerebral vascular disease.
Atherosclerosis. 1972 Mar-Apr;15(2):177-83. doi: 10.1016/0021-9150(72)90067-6.
Zotero 插件